Viewing Study NCT04829604

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:58 PM
Ignite Modification Date: 2026-01-01 @ 1:16 AM
Study NCT ID: NCT04829604
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-14
First Post: 2021-03-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)
Sponsor: Ambrx, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2 Positive Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HER2-postive View
None Breast cancer View
None Antibody drug View
None Metastatic View
None ARX788 View
None HER2 View